Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Sara V Carlini, Teresa Lanza di Scalea, Stephanie Trentacoste McNally, Janice Lester & Kristina M Deligiannidis. (2022) Management of Premenstrual Dysphoric Disorder: A Scoping Review. International Journal of Women's Health 14, pages 1783-1801.
Read now
Read now
Articles from other publishers (21)
Hao Zhang, Zhan Gao, Ya Sun, Tian Lu, Zhenzhen Wang, Dongmei Gao, Jieqiong wang, Mingqi Qiao & Mingzhou Gao. (2023) Profiling GABA(A) Receptor Subunit Expression in the Hippocampus of PMDD Rat Models Based on TCM Theories. Molecular Neurobiology 60:8, pages 4418-4428.
Crossref
Crossref
Qian Gao, Wei Sun, Yue-Rui Wang, Zi-Fa Li, Feng Zhao, Xi-Wen Geng, Kai-Yong Xu, Dan Chen, Kun Liu, Ying Xing, Wei Liu & Sheng Wei. (2023) Role of allopregnanolone-mediated γ-aminobutyric acid A receptor sensitivity in the pathogenesis of premenstrual dysphoric disorder: Toward precise targets for translational medicine and drug development. Frontiers in Psychiatry 14.
Crossref
Crossref
Nana Tetruashvili, Alice Domar & Asher Bashiri. (2023) Prevention of Pregnancy Loss: Combining Progestogen Treatment and Psychological Support. Journal of Clinical Medicine 12:5, pages 1827.
Crossref
Crossref
Ya Sun, Mingzhou Gao, Dongmei Gao, Dan Chen & Jieqiong Wang. (2023) Allopregnanolone-mediated GABAA-Rα4 function in amygdala and hippocampus of PMDD liver qi-invasion syndrome model rats. Aging.
Crossref
Crossref
Mingzhou Gao, Hao Zhang, Zhan Gao, Ya Sun, Guanghao Xu, Fengqin Wei, Jieqiong Wang & Dongmei Gao. (2022) Resident intruder paradigm-induced PMDD rat model of premenstrual irritability: behavioral phenotypes, drug intervention, and biomarkers. Aging 14:22, pages 9210-9220.
Crossref
Crossref
Maria Katharina Grötsch, Denise Margret Wietor, Timm Hettich & Ulrike Ehlert. (2022) Validation of a Commercial Enzyme-Linked Immunosorbent Assay for Allopregnanolone in the Saliva of Healthy Pregnant Women. Biomolecules 12:10, pages 1381.
Crossref
Crossref
Sheng Wei, Fushun Wang, Jianfeng Liu & Yang Wang. (2022) Editorial: Neural circuits and neuroendocrine mechanisms of major depressive disorder and premenstrual dysphoric disorder: Toward precise targets for translational medicine and drug development. Frontiers in Psychiatry 13.
Crossref
Crossref
Marcela Almeida & Sun J. Fletcher. (2022) Serious mental illness in women. Current Opinion in Psychiatry 35:3, pages 157-164.
Crossref
Crossref
Ariel B. Handy, Shelly F. Greenfield, Kimberly A. Yonkers & Laura A. Payne. (2022) Psychiatric Symptoms Across the Menstrual Cycle in Adult Women: A Comprehensive Review. Harvard Review of Psychiatry 30:2, pages 100-117.
Crossref
Crossref
Susan GordonSusan Gordon. 2022. The Mind-Brain Continuum. The Mind-Brain Continuum
123
136
.
Liisa Hantsoo, Christian Grillon, Mary Sammel, Rachel Johnson, Joanna Marks & C. Neill Epperson. (2021) Response to sertraline is associated with reduction in anxiety-potentiated startle in premenstrual dysphoric disorder. Psychopharmacology 238:10, pages 2985-2997.
Crossref
Crossref
Mingzhou Gao, Hui Sun, Xunshu Cheng, Dongmei Gao & Mingqi Qiao. (2021) Magnetic resonance imaging in mood disorders: a bibliometric analysis from 1999 to 2020. Clinical and Translational Imaging 9:3, pages 241-254.
Crossref
Crossref
Lindsay R. Standeven, Elizabeth Olson, Nicole Leistikow, Jennifer L. Payne, Lauren M. Osborne & Liisa Hantsoo. (2021) Polycystic Ovary Syndrome, Affective Symptoms, and Neuroactive Steroids: a Focus on Allopregnanolone. Current Psychiatry Reports 23:6.
Crossref
Crossref
Zachary A. Shalit, Lucas C. Valdes, Wan Shin Kim & Glenn C. Micalizio. (2021)
From an
ent
-Estrane, through a
nat
-Androstane, to the Total Synthesis of the Marine-Derived Δ
8,9
-Pregnene (+)-03219A
. Organic Letters 23:6, pages 2248-2252.
Crossref
Crossref
Elisa Rehbein, Jonas Hornung, Inger Sundström Poromaa & Birgit Derntl. (2021) Shaping of the Female Human Brain by Sex Hormones: A Review. Neuroendocrinology 111:3, pages 183-206.
Crossref
Crossref
Shelley N. Dolitsky, Christina N. Cordeiro Mitchell, Sarah Sheehan Stadler & James H. Segars. (2021) Efficacy of progestin-only treatment for the management of menopausal symptoms: a systematic review. Menopause 28:2, pages 217-224.
Crossref
Crossref
Tomoko Yoshida, Kazuki Saito, Toshihiro Kawamura, Tomonori Ishikawa, Tsuguhiko Kato, Keiko Matsubara, Naoyuki Miyasaka, Mami Miyado & Maki Fukami. (2021) Circulating steroids and mood disorders in patients with polycystic ovary syndrome. Steroids 165, pages 108748.
Crossref
Crossref
Taran Giddey, Natalie Thomas, Abdul-Rahman Hudaib, Elizabeth H.X. Thomas, Jessica Le, Paige Gray & Caroline Gurvich. (2020) Peak saccadic eye velocity across menstrual phases in naturally cycling women; A pilot study. Comprehensive Psychoneuroendocrinology 4, pages 100009.
Crossref
Crossref
Lindsay R. Standeven, Katherine O. McEvoy & Lauren M. Osborne. (2020) Progesterone, reproduction, and psychiatric illness. Best Practice & Research Clinical Obstetrics & Gynaecology 69, pages 108-126.
Crossref
Crossref
Md Soriful Islam, Sadia Afrin, Sara Isabel Jones & James Segars. (2020) Selective Progesterone Receptor Modulators—Mechanisms and Therapeutic Utility. Endocrine Reviews 41:5.
Crossref
Crossref
Lauren M. Osborne, Janneke Gilden, Astrid M. Kamperman, Witte J.G. Hoogendijk, Julie Spicer, Hemmo A. Drexhage & Veerle Bergink. (2020) T-cell defects and postpartum depression. Brain, Behavior, and Immunity 87, pages 397-403.
Crossref
Crossref